Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmed Kaseb

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|October 22, 2025
Perioperative camrelizumab plus rivoceranib versus surgery in resectable hepatocellular carcinomaAhmed Kaseb, Timothy M Pawlik
Oncotargets and Therapy|November 4, 2014
Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectivesManojkumar Bupathi, Ahmed Kaseb, Filip Janku
Liver Cancer|October 26, 2013
Surgical strategy for liver cancers in the era of effective chemotherapyJunichi Shindoh, Ahmed Kaseb, Jean-Nicolas Vauthey
The Surgical Clinics of North America|November 12, 2013
Management of hepatocellular carcinomaEmad H Asham, Ahmed Kaseb, R Mark Ghobrial
Hepatology (Baltimore, Md.)|November 10, 2020
REPLYJeffrey S Morris, Manal Hassan, Hesham Amin, et al.
The Oncologist|September 25, 2012
The effect of transcatheter arterial chemoembolization on hepatitis C viremiaParag Mahale, Ahmed Kaseb, Marta Davila, et al.
Hepatology (Baltimore, Md.)|November 10, 2020
REPLYJeffrey S Morris, Manal Hassan, Hesham Amin, et al.
Journal of Hepatocellular Carcinoma|December 11, 2019
Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With WolvesMohamed El Kassas, Ahmed Tawheed, Mohamed Eltabbakh, et al.
Chinese Clinical Oncology|January 14, 2021
Neoadjuvant and adjuvant treatment approaches for hepatocellular carcinoma: future outlookIbrahim Halil Sahin, Lana Khalil, Ralph Millett, et al.
Molecular Oncology|July 11, 2015
Hepatocellular carcinoma: Where there is unmet needManojkumar Bupathi, Ahmed Kaseb, Funda Meric-Bernstam, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|October 22, 2025
Perioperative camrelizumab plus rivoceranib versus surgery in resectable hepatocellular carcinomaAhmed Kaseb, Timothy M Pawlik
Oncotargets and Therapy|November 4, 2014
Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectivesManojkumar Bupathi, Ahmed Kaseb, Filip Janku
Liver Cancer|October 26, 2013
Surgical strategy for liver cancers in the era of effective chemotherapyJunichi Shindoh, Ahmed Kaseb, Jean-Nicolas Vauthey
The Surgical Clinics of North America|November 12, 2013
Management of hepatocellular carcinomaEmad H Asham, Ahmed Kaseb, R Mark Ghobrial
Hepatology (Baltimore, Md.)|November 10, 2020
REPLYJeffrey S Morris, Manal Hassan, Hesham Amin, et al.
The Oncologist|September 25, 2012
The effect of transcatheter arterial chemoembolization on hepatitis C viremiaParag Mahale, Ahmed Kaseb, Marta Davila, et al.
Hepatology (Baltimore, Md.)|November 10, 2020
REPLYJeffrey S Morris, Manal Hassan, Hesham Amin, et al.
Journal of Hepatocellular Carcinoma|December 11, 2019
Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With WolvesMohamed El Kassas, Ahmed Tawheed, Mohamed Eltabbakh, et al.
Chinese Clinical Oncology|January 14, 2021
Neoadjuvant and adjuvant treatment approaches for hepatocellular carcinoma: future outlookIbrahim Halil Sahin, Lana Khalil, Ralph Millett, et al.
Molecular Oncology|July 11, 2015
Hepatocellular carcinoma: Where there is unmet needManojkumar Bupathi, Ahmed Kaseb, Funda Meric-Bernstam, et al.
Pageof 10